Back to All Events

Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

  • IQVIA Solutions Denmark A/S Denmark (map)

On Wednesday, March 22, 2023, the PCNS advisory committee will discuss an NDA -215887, for tofersen (BIIB067) intrathecal injection, submitted by Biogen for the treatment of ALS associated with a mutation in the superoxide dismutase 1 gene.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/updated-meeting-time-and-public-participation-information-march-22-2023-meeting-peripheral-and
Earlier Event: March 16
Antimicrobial Drugs Advisory Committee
Later Event: April 14
The Psychopharmacologic Drugs Advisory Committee (PDAC)/Peripheral and Central Nervous System Drugs Advisory Committee (PDAC)